Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a
rhythm control strategy is pursued. We sought to summarize the current evidence on this …
rhythm control strategy is pursued. We sought to summarize the current evidence on this …
Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial
R Alcalai, A Butnaru, G Moravsky… - European Heart …, 2022 - academic.oup.com
Aims Current guidelines recommend anticoagulation with a vitamin K antagonist to treat left
ventricular (LV) thrombus after myocardial infarction (MI). Data on the use of direct oral …
ventricular (LV) thrombus after myocardial infarction (MI). Data on the use of direct oral …
Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
J Steffel - European Heart Journal Supplements, 2020 - academic.oup.com
Over the last 10 years since the introduction of non-vitamin K antagonist oral anticoagulants
(NOACs) into routine clinical practice our experience with these drugs has increased …
(NOACs) into routine clinical practice our experience with these drugs has increased …
[HTML][HTML] Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population
J de Heide, A de Wit, RE Bhagwandien, A Assaf… - International journal of …, 2021 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) have emerged as the preferred
choice of oral anticoagulation in patients with atrial fibrillation. Randomized trials have …
choice of oral anticoagulation in patients with atrial fibrillation. Randomized trials have …
Vorhofflimmern und NOAK-Therapie: Benötigen wir eine transösophageale Echokardiografie vor Kardioversion?
TB Baumeister, A Helfen, I Wickenbrock… - Aktuelle …, 2021 - thieme-connect.com
Vorhofflimmern ist ein häufiger Grund für einen Schlaganfall. Insbesondere Patienten ohne
adäquate Antikoagulation haben ein erhöhtes Risiko für thromboembolische Ereignisse (ca …
adäquate Antikoagulation haben ein erhöhtes Risiko für thromboembolische Ereignisse (ca …